Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exaluren in Alport Syndrome with Nonsense Mutations
NCT07523581Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of exaluren in Alport syndrome. Started Jun 2026; status: recruiting.
02
Drugs
exaluren
03
Conditions
Alport syndrome
Beyond the preview
Go deeper on NCT07523581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523581.